A Drug Interaction Study of the Pharmacokinetics of Topiramate and FLUNARIZINE When Given Together or Separately
Status:
Completed
Trial end date:
2004-03-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this open-label study is to determine if concomitant therapy with
topiramate and flunarizine has any effect on the pharmacokinetics of either drug. Safety will
be assessed for all subjects, for the entire duration of the study.
Phase:
Phase 1
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Collaborators:
Jan-Cil Italy Jan-Cil Spain Jan-Cil Switzerland Jan-Cil UK